Effi cacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes : a randomised , open-label , phase III study
暂无分享,去创建一个
J. Byrd | G. Mufti | J. Bennett | P. Fenaux | C. Finelli | S. Gore | E. Hellstrôm-Lindberg | A. Giagounidis | V. Santini | J. Seymour | N. Gattermann | G. Sanz | A. List | R. Schoch | J. Backstrom | D. McKenzie | L. Zimmerman | E. Hellstrom-Lindberg